Yazar "Kultursay, H." seçeneğine göre listele
Listeleniyor 1 - 11 / 11
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe ARDA study: Atherothrombosis recurrence in different vascular beds: Role of risk factors and treatment approaches(Elsevier Ireland Ltd, 2007) Oto, A.; Ongen, Z.; Kultursay, H.; Tokgozuoglu, L.; Ince, B.; Kumral, E.; Tuzun, H.Öğe Clinical and prognostic significance of heart rate variability in pulmonary arterial hypertension(Oxford Univ Press, 2014) Kayikcioglu, M.; Musayev, O.; Nalbantgil, S.; Mogulkoc, N.; Vuran, O.; Musayev, K.; Kultursay, H.Öğe Clinical and Prognostic Significance of Heart Rate Variability in Pulmonary Hypertension(Elsevier Science Inc, 2014) Musayev, O.; Kayikcioglu, M.; Nalbantgil, S.; Mogulkoc, N.; Vuran, O.; Musayev, K.; Kultursay, H.Öğe Comparison of cardiac output measurement methods for mortality prediction in pulmonary hypertension(Oxford Univ Press, 2018) Simsek, E.; Bayazit, Y.; Demir, E.; Kayikcioglu, M.; Nalbantgil, S.; Mogolkoc, N.; Can, L.; Kultursay, H.Öğe THE COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO ENOXAPARIN PLUS ADJUSTED-DOSE WARFARIN FOR THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT) IN TURKEY(Elsevier Science Inc, 2013) Parali, E.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.; Ongen, Z.; Deger, C.; Marmarali, B.; Ozel, M. O.; Sumer, F.; Tuna, E.; Yilmaz, Z. S.Öğe THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY(Elsevier Science Inc, 2013) Marmarali, B.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.; Ongen, Z.; Deger, C.; Ozel, M. O.; Parali, E.; Sumer, F.; Tuna, E.; Yilmaz, Z. S.Öğe THE COST-OF-DISEASE OF DEEP VENOUS THROMBOSIS AND ITS SHORT- AND LONG-TERM CLINICAL CONSEQUENCES IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS(Elsevier Science Inc, 2013) Deger, C.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.; Ongen, Z.; Marmarali, B.; Ozel, M. O.; Parali, E.; Sumer, F.; Tuna, E.; Yilmaz, Z. S.Öğe THE COST-OF-DISEASE OF THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION AND ITS TREATMENT IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS(Elsevier Science Inc, 2013) Deger, C.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.; Ongen, Z.; Marmarali, B.; Ozel, M. O.; Parali, E.; Sumer, F.; Tuna, E.; Yilmaz, Z. S.Öğe Increased TIMI frame counts in patients without significant coronary atherosclerosis but with left ventricular dysfunction during dobutamine stress echocardiography(Oxford Univ Press, 2005) Yavuzgil, O.; Gurgun, C.; Ildizli, M.; Cinar, C. S.; Ozerkan, F.; Kultursay, H.Öğe OUR RESULTS OF ALCOHOL SEPTAL ABLATION IN SYMPTOMATIC PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY(Elsevier Ireland Ltd, 2011) Yavuzgil, O.; Tuluce, K.; Gurgun, C.; Kultursay, H.; Payzin, S.; Hasdemir, C.; Can, L. H.; Turkoglu, C.Öğe Short-term statin treatment has beneficial effects on cardiac functions and inflammation in chronic heart failure(Oxford Univ Press, 2006) Gurgun, C.; Ildizli, M.; Yavuzgil, O.; Sin, A.; Apaydin, A.; Cinar, C.; Kultursay, H.